Valmark Advisers Inc. Makes New $225,000 Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Valmark Advisers Inc. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,659 shares of the financial services provider’s stock, valued at approximately $225,000.

Several other large investors have also made changes to their positions in IBB. International Assets Investment Management LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $76,425,000. Itau Unibanco Holding S.A. acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $48,242,000. Tower Research Capital LLC TRC lifted its holdings in iShares Biotechnology ETF by 28,138.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock valued at $12,052,000 after purchasing an additional 98,203 shares in the last quarter. Calamos Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth $7,648,000. Finally, Cumberland Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $6,297,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.5 %

Shares of NASDAQ IBB opened at $128.37 on Tuesday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The firm has a 50-day simple moving average of $134.12 and a 200-day simple moving average of $129.88.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.39%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.